Use of complementary and alternative medicine in patients with liver disease
Use of complementary and alternative medicine in patients with liver disease
复制标题
DOI：
10.1111/j.1572-0241.2002.05993.x
复制
发表时间：
2002-09-01
影响因子：
9.8
通讯作者：
Seeff, LB
中科院分区：
文献类型：
--
作者：
Strader, DB;Bacon, BR;Seeff, LB
补充和替代医学（CAM）被42%的美国人口使用。它在慢性肝病患者中的使用尚未得到很好的定义。为此，我们调查了患者在六个地理位置不同的肝病诊所在美国使用CAM.METHODS：参加六个肝病诊所的患者进行了调查，通过一个共同的问卷调查关于他们使用CAM。获得人口统计学信息以确定CAM使用的预测因素。统计分析包括单因素和多因素Logistic回归分析。结果：共989例患者完成问卷。其中，389人（39%）承认在前一个月内至少使用过一次某种形式的CAM; 21%承认使用过草药制剂，13%使用草药治疗肝病。发现五个变量可预测替代疗法的用途：女性、年轻、教育水平、年收入和地理位置。在所有的，74%的患者报告使用CAM除了他们的医生开的药，但26%没有通知他们的医生CAM use.CONCLUSIONS：CAM的使用是常见的患者之间访问肝病诊所在美国的一般人群（39%vs 42%）。许多患者正在使用草药治疗肝病，但拒绝与医生讨论这种用途。
OBJECTIVES: Complementary and alternative medicine (CAM) is used by 42% of the U.S. population. Its use among patients with chronic liver disease has not been well defined. Toward that end, we surveyed patients in six geographically diverse liver disease clinics in the United States for use of CAM.METHODS: Patients attending six liver disease clinics were polled via a common questionnaire regarding their use of CAM. Demographic information was obtained to identify predictors of CAM use. Statistical analysis included univariate and multivariate analysis using logistic regression.RESULTS: A total of 989 patients completed the questionnaire. Of these, 389 (39%) admitted to using some form of CAM at least once during the preceding month; 21% admitted to using herbal preparations, and 13% used herbs to treat their liver disease. Five variables were found to be predictive of alternative therapy use: female sex, young age, level of education, annual income, and geographic location. In all, 74% of patients reported using CAM in addition to the medications prescribed by their physician, but 26% did not inform their physician of their CAM use.CONCLUSIONS: CAM use is as common among patients visiting liver disease clinics in the United States as in the general population (39% vs 42%). Many patients are using herbs to treat their liver disease but are declining to discuss this use with their physician.